MAVS anticorps (N-Term)
Aperçu rapide pour MAVS anticorps (N-Term) (ABIN1881530)
Antigène
Voir toutes MAVS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1-30, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This Mouse Mavs antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of mouse Mavs.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
-
: "Influenza virus activates inflammasomes via its intracellular M2 ion channel." dans: Nature immunology, Vol. 11, Issue 5, pp. 404-10, (2010) (PubMed).
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Autre désignation
- Mavs
-
Sujet
- Required for innate immune defense against viruses. Acts downstream of DDX58 and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis (By similarity).
-
Poids moléculaire
- 53399
-
NCBI Accession
- NP_001193314, NP_659137
-
UniProt
- Q8VCF0
-
Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Antigène
-